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Summary Cervical carcinoma and cervical intra-epithelial neoplasia (CIN) are likely to be associated with all
sexually transmitted diseases (STDs). To help discover which (if any) of the recognised STDs might actually
cause these conditions, a key question is whether one particular such association is much stronger than the
others. The present study is therefore only of women newly attending an STD clinic, and compares the
prevalences of cytological abnormalities of the cervix among 415 women attending with genital warts, 135
with genital herpes, and 458 with trichomoniasis or gonorrhoea. Significantly more genital wart patients
(8.1%) than trichomoniasis or gonorrhoea patients (1.9%) showed dyskaryotic changes (adjusted relative risk
(RR)=5.8 with 95% limits 2.5-13.5) at, or a few months before, first attendance, while no excess whatever
was seen in women with genital herpes. Moreover, half the women had a subsequent smear (at an average of
3-4 years after first attendance) and, although the diagnosis at first attendance was not related to the onset
rate of dyskaryotic changes observed in these subsequent smears, it was related to the onset rate of grade III
cervical intra-epithelial neoplasia (CIN III), which was found in 7 previous genital wart patients, in 2 previous
trichomonas patients, but in 0 previous genital herpes patients. Thus, our findings suggest that herpes is not
directly relevant to dyskaryotic change, but that one or more of the human papilloma viruses that cause
genital warts may be.
Although it has long been suspected that cervical
cancer is of venereal origin (Kessler, 1976), it has
proved remarkably difficult to determine whether
any of the known sexually transmitted infective
agents are responsible for it, and, if so, which one
chiefly is. This is partly because the patterns of
behaviour, either by the woman or by her
partner(s), that predispose to any one particular
type of sexually transmitted disease (STD) are likely
also to predispose to others, producing strong but
non-causal associations of cervical cancer risk with
many different STDs. Any truly causative STD
must, therefore, show not merely an association
with cervical cancer, but in particular an
association that is much stronger than that for
other STDs.
The tendency for all STDs to be associated with
each other, and hence with cervical cancer, has not
always been properly allowed for, and it alone
probably accounts for the reported associations of
the neoplasm with syphilis, gonorrhoea, and
trichomoniasis (Alexander, 1973). If, however, the
causative agent is not some hitherto unrecognised
organism, then the most plausible candidates at
present are perhaps herpes simplex virus type II
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(HSV2) or some type(s) of human papilloma virus
(HPV).
At first sight, HSV2 fits the requirements for
venereal carcinogen rather well. Women with
cervical cancer have consistently been shown to
have higher levels of antibodies to various HSV2
antigens than controls (Rawls & Adam, 1977;
Aurelian, 1980) and HSV2-specific RNA, though
not DNA (Eglin et al, 1981), has occasionally been
detected in the nuclei of cells from cervical
carcinomas. Nevertheless, some inconsistencies still
remain, and in a recent review article (Waterson,
1982) the conclusion about HSV2 was merely that
"much epidemiological work has so far failed to
transform suspicion into certainty".
The other plausible candidate, HPV, should
really be thought of as a set of candidate viruses,
for it includes several distinct viral types (Tooze,
1981), all of which are small DNA viruses. In
humans, the type(s) chiefly responsible for warts on
the hands differ from the venereally transmitted
type(s) chiefly responsible for genital warts (GW)
(condylomata acuminata); but it is not yet known
how many distinct types and subtypes of venereally
transmitted HPV exist. On the cervix itself HPV
infection can induce lesions ranging from recently
recognised subclinical changes-involving, on
cytological examination of a cervical smear,
features such as "koilocytotic atypia" (nuclear
enlargment and irregularity, with a perinuclear
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halo) and/or, on colposcopic examination of the
cervix itself, asymptomatic features such as "flat"
warts-to the classical findings of raised (i.e.
papillomatous) warts (Meisels et al., 1977).
However, although papillomatous warts provide
specific evidence of HPV infection, it is not known
to what extent koilocytotic atypia does likewise.
Malignant transformation has been reported in
dozens of papillomatous GW in various parts of
the male and female genital tract (Boxer & Skinner,
1977) and also in flat warts (Shokri-Tabibzadeh,
1981), and at least some of the few genital
neoplasms so far investigated (2 vulvar carcinomas,
6 cervical carcinomas and 3 cervical carcinomas in
situ) contained papilloma virus DNA (zur Hausen,
1982).*
Difficulties in assessing HPV infection ofthe cervix
When attention was restricted to clinical
papillomatous warts, HPV infection of the cervix
itself was thought to be very rare. If, however, all
of its possible manifestations (including flat warts
and/or koilocytotic atypia) are included, then
among large series of asymptomatic women
attending cervical screening clinics at least 1%
appear to have cytological evidence suggestive of
such infections (Reid et al., 1980; Meisels et al.,
1977). Moreover among women with frank warts
elsewhere in the genital tract, such cytological or
histological changes in the cervix may be detected
in 10-50% (Jagella & Stegner, 1974; Purola &
Savia, 1977; Baggish, 1980). All of these
percentages may eventually require substantial
revision, however, for neither the sensitivity nor the
specificity of cytological findings have yet been
established as indicators of infection of the cervix
by one or other type of HPV.
Indeed, the difficulty of determining reliably
exactly who has (or has had) genital HPV (leave
alone of any particular type) is a serious obstacle to
progress in this field. Even in infected cells, viral
particles-detectable by electron microscopy or by
immunoperoxidase techniques-may be uncommon
and although serum antibodies to genital HPV
infection do form, they cannot at present be
distinguished reliably from antibodies to the widely
prevalent common warts of other parts of the body,
such as the hands or feet. DNA probes for certain
HPV types have recently emerged, but it remains to
be seen how convenient and reliable tests based on
these will be.
*In addition, Durst, Gissman, Ickenberg, and Zur Hausen
(personal communication) have recently discovered what
appears to be a new type of HPV (tentatively designated
HPV16), evidence for which has been found in about half
of the first few dozen cervical carcinomas examined.
Using histological methods to classify the cervical
epithelium, Reid et al. (1982) reported that out of
80 women with cervical neoplastic changes
(including 40 with evidence of invasion) 73 showed
"subclinical papillomavirus infection" (SPI) while
the remaining 7 showed "suspicious SPI". By
contrast, 60/80 control cases were negative, 10
showed "suspicious SPI" and only 10 satisfied the
full criteria for "SPI". If Reid's findings, or
something like them, could be reproduced using
more direct measurements of (preferably type-
specific) HPV infection then they would provide
strong evidence that HPV is indeed an important
cause of cervical cancer. However, other workers,
using different criteria, have not reported such
extreme associations (Syrjanen et al., 1981), and it
is still possible that the changes referred to as
"SPI" are due in part to some different viral
infection, or to some indirect effects of the
neoplasms themselves or of the preneoplastic
conditions from which they arose. In short, we have
no grounds for knowing the extent to which the
cytological features of "SPI" are specific for HPV
infection. Therefore, until reliable methods are
available for the detection of HPV in cervical cells,
a reliable diagnosis of infection can (in the absence
of immunochemical or EM investigations) be made
only in the presence of warts. At the ages when
these are common, however, neoplastic changes in
the cervix (carcinoma-in-situ or worse) are rare and
substantial amounts of information can be obtained
only for the lesser degrees of dysplasia, as
evidenced in smears by "dyskaryosis". In the
present study we have, therefore, sought to
establish whether dyskaryosis is associated any
more strongly with clinical GW than with genital
herpes or other venereal infections.
Patients and methods
Patients
From the outpatients list of the Sexually
Transmitted Diseases Clinic at the Radcliffe
Infirmary, Oxford, women were selected who: (i)
first attended in 1972-8; (ii) were white and resident
in Oxfordshire; (iii) had not previously undergone
hysterectomy; and (iv) had a diagnosis on first
attendance of one of (a) genital warts (GW), (b)
genital herpes simplex virus infection (HSV), or (c)
Trichomonas vaginalis (TV) or gonorrhoea (GR).
All women at first attendance for GW (415) and
HSV (135) were included while a 50% sample was
chosen (by alternation) of patients with TV (216)
and GR (242). The HSV group included 19 patients
with HSV1 infection, 90 with HSV2, and 26 with
HSV of unspecified type.CYTOLOGICAL EVIDENCE OF HPV INFECTION 623
Alternate women attending for TV or GR were
chosen for investigation, rather than all the women
attending for one or other disease, in the hope of
obtaining a more representative sample of women
at risk of developing STDs than might be obtained
if the comparison group were limited to one disease
only. In the event, the results obtained for women
in the two categories were closely similar and they
have, therefore, been treated as constituting a single
group for comparison in all the analyses.
Information was also sought on age, date of
birth, occupation, reproductive history,
contraceptive practice, sexual behaviour over the 6
preceding months, and subsequent attendance for
recurrences of venereal diseases. Table I shows that,
compared to the other women, GW patients were
quite different. They were younger, more were
students, more were employed in clerical jobs, more
were nulliparous, and more were users of oral
contraceptives. In addition, they had on the average
had fewer partners during the previous six months.
Women with herpetic lesions showed somewhat
intermediate features, but were rather similar to
GW patients in their occupations and numbers of
partners.
Many women (49.9% of GW, 51.9% of HSV
Table I Characteristics of 1,008 women attending Oxford STD Clinic in relation
to diagnosis ofvenereal disease.
Trichomonas or
Genital Warts Genital Herpes Gonorrhoea
(415 women) (135 women) (458 women)
Chi-square' Chi-square'
(%) test statistic (%) test statistic (%)
Age (years)
< 19 43.6 24.44 30.4 32.3
20-24 37.3 (df= 1; 34.8 (NS) 33.2
>25 19.0 P<0.001) 34.8 34.5
Occupation
Student 29.6 25.9 12.7
Clerical worker 32.0 30.4 26.6
Manual worker or
sales assistant 22.2 60.48 21.5 17.80 27.3
Housewife or (df=3; (df=3;
unemployed 16.1 P<0.001) 22.2 P<0.001) 33.4
Marital status
Single 76.1 (N) 653 (N)62.7 Ever-married 2319 (NS) 34.8 (NS)
No. ofchildren
None 86.0 16.132 72.6 64.33
14.0 27.4 (NS) 35.7
(P<0.00l)
Oral contraceptives4
User 66.3 5.45 60.0 55.2
Non-user 33.7 40.0 (NS) 44.8
(P<0.02)
Recent partners4
1 65.8 22.702 63.7 4.752 55.9
2 27.7 (df= 1; 26.7 (df= 1; 25.8
>,3 6.5 P<0.001) 9.6 P<0.03) 18.3
1x2 test for heterogeneity or, where appropriate, trend, comparing percentage
distribution of characteristic with that among women with trichomonas or
gonorrhoea. NS=not significant.
2Adjusted for age (< 19; 20-24; >25 years) and occupation (student/clerical vs.
others) by the Mantel Haenszel procedure.
3Excluding one woman with unrecorded parity.
4In the 6 months preceding attendance.624 S. FRANCESCHI et al.
and 38.2% of TV/GR) were also suffering from
other genital infections at first attendance, chiefly
candidiasis or unspecific vaginal discharge, and
many (23.4% of GW, 30.1% of HSV and 30.3% of
TV/GR) were referred back to the STD clinic
during the subsequent 1-10 years, either for the
same disease or for a different condition. 9.9% of
the GW patients were referred back for a
recurrence and 5.9% of HSV and 3.7% of TV/GR
women were referred back for a first onset of GW.
Among 1,008 women included in the present
study, 92.3% of GW, 90.3% of HSV and 89.7% of
TV/GR women had a cervical smear taken at first
attendance or had had one within the previous 6
months, and the findings of these smears are the
chief subject of the present study. In addition, the
records of the Cytology Department of the
Churchill Hospital, Oxford, were scanned for
previous and subsequent smear results on these
women, whether from the STD clinic or elsewhere
(general practitioners, family planning clinics, etc.).
These records contained reports on all cervical
smears examined cytologically in the area and
provided our only means of follow up, because the
policy of the STD Department did not permit
patients to be recalled for the purpose of the study.
In 52.7% of GW, 52.5% of HSV and 51.6% of
TV/GR patients, subsequent smear(s) were
identified, and where this happened the mean
numbers were respectively 2.0, 2.0 and 1.9
subsequent smears at 12-120 (means respectively
43, 38 and 47) months after entry. In addition,
some information on the cytological status of the
cervix more than 6 months before referral to the
STD clinic was found in 16.9% of GW, 24.4% of
HSV and 25.3% of other women.
Cytology
All smears were reviewed by one of us (AIS) and
classified into 4 groups: (i) normal, (ii)
inflammatory, (iii) superficial (mild) dyskaryosis
(large, hyperchromatic, irregular nuclei in cells with
normal or near-normal maturation, corresponding
to mild/moderate dysplasia or CIN I-TI), and (iv)
parabasal dyskaryosis (poor cytoplasmic
differentiation, corresponding to severe
dysplasia/carcinoma in situ or CIN III) (Spriggs et
al., 1978). Separation of "koilocytotic atypia" from
dyskaryosis was not considered reliable but
characteristics pointing to HPV infection
(koilocytosis, binucleation and multinucleation, and
presence of orange-stained cells with pyknotic
nuclei) were assessed "blindly" in all dyskaryotic
smears. Biopsy, electrocoagulation diathermy or
other treatment of the cervix was not considered for
mild dyskaryosis unless the lesion persisted for at
least 6-12 months. Since in most cases of
dyskaryosis there was spontaneous "regression" to
a negative smear, no biopsy was done and so no
histological diagnosis is reported.
Statistics
Test of the statistical significance of any apparent
differences were based on standard chi-square tests
for trend or for heterogeneity (with correction for
continuity in the particular "2 x 2" case of a 2-
group comparison of a 2-level quantity).
Differences between cases and controls in age and
occupation were adjusted for by the method of
Mantel (1963) or Mantel & Haenszel (1959). Odds
ratios (as estimates of relative risks, RR) and their
approximate 95% confidence intervals (CI) were
also calculated (Miettinen, 1976).
Results
Cytologicalfindings atfirst attendance
Significantly more women with GW than women
with other STDs presented with some degree of
dyskaryosis (Table II). Among screened patients, 31
(8.1%) of the GW series were found to have
superficial dyskaryosis compared to 8 (1.9%) of the
women with TV/GR. The estimated relative risk
(RR) for the occurrence of dyskaryotic smears in
GW compared to TV/GR was 4.4 (95% CI: 2.1-
14.7). After adjustment for age and occupational
group, this relative risk increased to 5.8 (95% CI:
2.5-13.5). Clinical HPV infection of the cervix was
associated with an even higher rate of superficial
dyskaryosis (8/36 vs 23/347, X2=8.65, P<0.01) and
for this group of patients the estimated relative risk
would have been greater still. By contrast, among
screened patients with herpetic lesions, only 2
(1.6%) presented with dyskaryosis (RR=0.8).
In line with the general policy of the clinic,
treatment (including cervical biopsy) was deferred
for 6-12 months in all 40 women showing mild
dyskaryosis. The only woman with severe
dyskaryosis (a TV patient) was biopsied
immediately and this revealed a microinvasive
cervical carcinoma. She was treated by
hysterectomy.
Previous cytologicalfindings
Some degree of dyskaryosis has been reported
before clinical evidence of venereal disease in 6
(8.6%) of 70 GW patients (6 years before in one
case and 2 years before in the others), in none of
the 33 HSV patients, and in 4 (3.4%) of the 116
TV/GR patients (1, 2 and 3 years before the first
attendance) (Table III). Although this excess is
similar in direction to that observed at entry to theCYTOLOGICAL EVIDENCE OF HPV INFECTION 625
Table II Cytological findings at, or within 6 months before, first attendance at Oxford STD
Clinic, in relation to diagnosis ofvenereal disease.
Other
Genital Warts Genital Herpes (Trichomonas/Gonorrhoea)
Cytological No. of % No. of % No. of %
finding women ofsmears women ofsmears women ofsmears
No smear
taken 32 13 - 47
Negative 296 (77.3) 97 (79.5) 296 (72.0)
Inflammatory 56 (14.6) 23 (19.9) 107 (26.0)
Superficial
dyskaryosis or
worsel 31 (8.1) 2 (1.6) 8 (1.9)
RR (and 95% 4.42 0.8 (1.0)3
CI) for (2.1-14.7) (0.1-7.1)
dyskaryosis or
worse
'The only "worse" than superficial dyskaryosis finding was a woman aged 44 with TV and
microinvasive cervical carcinoma treated by hysterectomy.
2RR (adjusted for age and occupational group by the Mantel-Haenszel procedure)=5.8 (95%
CI: 2.5-13.5).
3Reference category.
Table III Cytological findings more than 6 months before first attendance at Oxford STD Clinic, in
relation to eventual diagnosis of venereal disease at the Clinic.
Other
Genital Warts Genital Herpes (Trichomonas/Gonorrhoea)
Cytologicalfinding
(more than 6 months No. of % No. of % No. of %
earlier) women ofsmears women ofsmears women ofsmears
No smear available 345 102 342
Negative 64 (91.4) 33 (100.0) 112 (96.6)
Superficial dyskaryosis
or worse 6 (8.6) 0 - 4 (3.4)
RR (and 95% 2.62 (1.0)3
CI) for dyskaryosis (0.5-13.4)
or worse
'On the average, 2 years earlier.
2RR (adjusted for age by the Mantel Haenszel procedure)=2.5. (95% CI: 0.5-13.1).
3Reference category.
study, it is based on such small numbers that it is
not statistically significant (and would not be so
even if the HSV patients were pooled with the TV
and GR patients).
Among the 6 GW women and the 4 TV/GR
women who had had dyskaryosis in the years
preceding the diagnosis of the specified venereal
disease, 3 and one respectively still showed it at
entrance.
Subsequent cytologicalfindings
The percentages of women who were re-examined,
the mean numbers of smears, and the mean lengths
of follow-up were very similar in the 3 groups (see
Patients above). Surprisingly, in view of the
findings at first attendance, the proportions with no
cytological abnormality at entry who developed
abnormalities were also rather similar in each group626 S. FRANCESCHI et al.
(9.8% in 174 GW, 7.9% in 63 HSV, and 9.0% in
201 TV/GR women). Among women previously
having superficial dyskaryosis, the condition
persisted or worsened in 12/28 GW and 4/6 TV/GR
women (including in the 4 the women who initially
showed micro-invasive cervical carcinoma and had
a hysterectomy) and regressed to normal in the one
such women who had presented with HSV.
Some women, with or without clinical GW
initially, presented with GW 1-10 years later, and
all the available data on the occurrence of genital
warts and dyskaryosis at first attendance or later
are summarised in Table IV. These include
observations on 16 women who had their first
smear taken only a year or more after their first
attendance. Dyskaryosis was observed in one
woman in this last group who presented initially
with GW and returned to the clinic 7 years later for
another reason.
Histologicalfindings
Histological examination of cervical biopsies or
larger specimens at cone biopsy or hysterectomy,
which was carried out only in cases of "parabasal
cell dyskaryosis" or if "superficial cell dyskaryosis"
persisted for 6-12 months, revealed 2 cases of
micro-invasive cancer and 7 cases of grade III
cervical intra-epithelial carcinoma. Six of the latter
occurred in women who attended with GW (4 in
women aged 21, 22, 22, and 26 years who returned
to the clinic more than a year after having had
negative smears at their first attendance and 2 in
women aged 22 and 23 years who returned later
having originally had mildly dyskaryotic smears)
and only one occurred in any other group (in a
woman aged 28 years who presented with TV, was
found to have mild dyskaryosis, and subsequently
returned with a persisting lesion). The cases of
micro-invasive cancer occurred in (i) a woman aged
26 years who failed to have a smear taken on her
initial visit to the clinic for GW 7 years previously
and had returned for another reason, and (ii) the
women aged 44 years at her first visit for TV, who
has been referred to previously. A micro-invasive
carcinoma of the vulva was also found in one of
the women with GW who were found to have CIN
III of the cervix at a subsequent attendance. The
detailed distribution of all these cases is shown in
the footnotes to Table IV.
Changes in cytological smears "suggestive" of HPV
infection
Among women with dyskaryotic changes,
cytological features that have been regarded as
suggestive of HPV infection (see above) were
present in 17/31 GW, 1/2 HSV and 2/8 other
women at entry and in 7/28 GW, 2/5 HSV, and 5/20
other women at follow up. In our series, these
features did not seem to be specific for patients
with HPV infections unless a high proportion of
Table IV Cytotological findings at, and subsequently to first attendance at Oxford STDs Clinic, in relation to
initial disease and subsequent development of genital warts (N= 1008).
Other at entry
Genital Warts at entry (Herpes/Trichomonas/Gonorrhoea)
Negative Dyskaryotic Negative Dyskaryotic
smear at smear at No smear smear at smear at No smear
entry entry at entry entry entry at entry
Subsequent smear(s)
(a) Presented with genital warts
(1) Negative smear 21 2 0 13 0 1
(2) Dyskaryotic smear 3(1)2 3 0 2 0 0
(b) Other reason'
(i) Negative smear 136 14 3 228 3 11
(ii) Dyskaryotic smear 14(3)2 9(2)2 1(1)2 21 4(2)2 0
(c) No smear since entry
178 3 28 259 3 48
Total 352 31 32 523 10 60
'Includes attendance at STD Clinic for other venereal diseases and attendance at all other clinics.
2The figures in brackets give the numbers of the women in each cell of this table among whom CIN III or
microinvasive cancer was found after first attendance at the STD clinic. They include the woman with TV who had
a hysterectomy for microinvasive cancer at her first attendance.CYTOLOGICAL EVIDENCE OF HPV INFECTION 627
women with other venereal infections also have
subclinical wart virus infection.
Discussion
There are two main sources of difficulty in
interpreting these data. The first is purely
epidemiological; because of the effects of the play
of chance when only small numbers of events are
studied, because of the crudeness of our measures
of HPV infection, and because of the
incompleteness of the available data (many women
did not have a prior or a subsequent smear, and
even those who did had only one or a few such
smears, perhaps with long intervals between them),
there is uncertainty about both the strength and the
time course of the association between HPV
infection and dyskaryosis. Indeed, the follow-up
data, in which the onset rate of dyskaryosis is
similar in GW, HSV, and TV/GR patients, stand in
such marked contrast to the entry data, where the
prevalence of dyskaryosis was far lower in the HSV
and TV/GR patients than in the GW patients, that
no plausible model springs to mind that can
embrace both sets of observations without
assuming that one, or other, or both have been
substantially distorted by the play of chance.
Perhaps the most plausible interpretation of the
available data is that (i) there is no indication
whatever of any association of herpes simplex
infection with dyskaryosis or carcinoma-in-situ, and
that (ii) there is strong evidence, chiefly from the
entry data, for an association of HPV infection
with dyskaryosis that is closer than the associations
of certain other sexually transmitted diseases with
dyskaryosis. But in the light of the follow-up data,
the true association (i.e. the association that would
be found at entry in a far larger study) is probably
less close than is suggested by the present entry
data. Further such studies could clarify this point.
We must note, that women who attended an STD
clinic for the selected conditions may not be typical
of the entire population of affected women, nor
may those who had had previous cervical smears or
had them taken again during the follow-up period
be typical of those who had smears taken on their
first attendance at the clinic. It is unlikely, however,
that any such atypicality could have materially
affected the comparisons between the three STD
groups with which we are concerned, as the
percentages of those who had smears were so
similar (see Patients above).
The second source of difficulty is biological, and
is concerned with the nature of the dyskaryotic
lesions that we have shown to be associated with
genital warts. There are terminological difficulties
(for example, many others might use the word
dysplastic instead of dyskaryotic), but these are less
important than the difficulties that derive from
ignorance of the usual natural history of such
lesions. Particularly, even if it were accepted that
some type(s) of dysplastic change could predispose
to malignant change, how homogeneous a category
is "dysplastic lesions"? Unfortunately, no follow-up
study dealing with different types of dysplastic
lesion has been large and long enough to establish
the existence of different types of dysplasia that
differ in their natural history (Boon & Fox, 1981;
Meisels et al., 1981) and chromosomal analysis of
mild dysplasias has not been possible because of
their low mitotic activity (Spriggs, 1974).
If it is accepted that some types of HPV infection
can cause "koilocytotic atypia" (Koss, 1979;
Meisels et al., 1977) then, since such lesions will
often* be classified as "dysplastic", HPV can
indeed cause at least one category of "dysplasia".
But, is this category of dysplasia that is produced
by HPV infection one that has no important
relationship to malignant change? If so, HPV may
be of little importance. Conversely, if dysplastic (or,
more strictly, dyskaryotic) changes constitute a
biological continuum, and if they can predispose to
malignant change, then our evidence that HPV is a
major cause of dysplasia tends to incriminate one
or more of the types of HPV as being a likely cause
(though not necessarily the only important cause)
of cervical cancer. An indication that this may
indeed be the case is provided by the observation
(Table IV) that 7/206 women with an initial
diagnosis of genital warts progressed to a grade III
cervical intra-epithelial neoplasm (CIN III), as
opposed to only 1/282 other women (excluding the
women who initially underwent hysterectomy).
These numbers are small, however, and the follow-
up is incomplete; moreover, although CIN III
appears to be a considerably more sinister lesion
than those characterised only by superficial
dyskaryosis, it is still not a malignant neoplasm, so
some reservations about its relevance may also be
justified.
Although these uncertainties are substantial, they
do not entirely eclipse our findings. The
epidemiological evidence that cervical cancer is
generally caused by a venereally transmitted
infective agent is overwhelming, and laboratory and
*In our series, it should be noted the presence of
"Koilocytotic atypia" was not regarded as sufficient
evidence to apply the term dyskaryosis (and, when
dyskaryosis was reported, the proportion of cases in
which koilocytotic atypia was apparent was only very
slightly higher among GW patients than among TV or
HSV patients).628 S. FRANCESCHI et al.
other evidence suggests that herpes simplex and/or
some types of human papilloma virus might be
chiefly responsible (Zur Hausen, 1982), but does
not yet point strongly to either. Whatever other
conclusions may be drawn from our study, it most
certainly does not show any association between
genital herpes and either the immediate onset of
dyskaryosis, or the onset over the next few years of
CIN III. Our data weigh, therefore, quite heavily
against any role for the common type(s) of genital
herpes in causing dyskaryotic, and hence perhaps
malignant, changes in the uterine cervix.
Consequently, our data indict HPV not only
directly, by showing its association with dyskaryosis
and suggesting its association with CIN III, but
also indirectly, by producing evidence against the
relevance of the most plausible alternative to HPV
as a causative factor of cervical cancer. If, however,
it proves that only some types of HPV are
responsible, progress is likely to be slow until they
can readily be detected from others.
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